Skip to main content

Consultation on derogation to exclusion for 2 active substances

Andrew Maxey 3 years ago   Reply
Dear Biocides active substances web community member, Garry Wiles used to circulate via this community relevant consultations and updates from the European Chemicals Agency (ECHA). Garry retired in August and his successor takes up post in October. Hence, while I am not formally the Community Manager, I am circulating details on this occasion. The ECHA's Biocidal Product Committee recently adopted its opinions on the approval of 2 active substances, available on the ECHA website ( ) : - Reaction products of paraformaldehyde and 2- hydroxypropylamine (ratio 1:1) (originally notified as HPT) in product-types 2, 6, 11 and 13. - Reaction products of paraformaldehyde and 2- hydroxypropylamine (ratio 3:2) (originally notified as MBO) in product-types 2, 6, 11, 12 and 13. These active substances meet the exclusion criteria set out under Article 5(1) of Regulation (EU) No 528/2012 (the BPR). Active substances meeting the exclusion criteria should not be approved unless it is shown that at least one of the conditions for derogation set out in Article 5(2) of that Regulation is met. In that context, a consultation is therefore made in order to gather information to demonstrate whether or not one or several of the following conditions for derogation are met: (a) the risk to humans, animals or the environment from exposure to the active substance in a biocidal product, under realistic worst case conditions of use, is negligible, in particular where the product is used in closed systems or under other conditions which aim at excluding contact with humans and release into the environment; (b) it is shown by evidence that the active substance is essential to prevent or control a serious danger to human health, animal health or the environment; or (c) not approving the active substance would have a disproportionate negative impact on society when compared with the risk to human health, animal health or the environment arising from the use of the substance. ECHA invites Member States and interested parties to contribute to this consultation to indicate if they consider that one or more of the conditions set out under Article 5(2) of the BPR are met, or if none of these conditions is met, and to provide justifications. This consultation is open for a period of 60 days from its start, contributions shall therefore be sent by 4 November 2017 at the latest. The Commission together with Member States will take into account the information collected in order to decide whether or not to approve of these active substances for these product-types. You can find more information on this public consultation from the ECHA website: It is important that you read carefully the section "How to submit a contribution to the public consultation?", and follow the instructions given therein to send a contribution.